Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Preclinical Development: Overview

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

Clinically Relevant Drug Product Specifications: Methods of Establishment

Clinically Relevant Drug Product Specifications: Methods of Establishment

Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...

Bioequivalence studies: Biowaivers

Bioequivalence studies: Biowaivers

In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...

Nursing Evaluation

Nursing Evaluation

The evaluation stage signals the end of the nursing process. The nurse gathers evaluative data to assess whether or not the patient has attained the expected results. Whereas the nurse collects data in the nursing assessment to identify the patient's health concerns, the evaluation stage data determines if the indicated health issues are resolved. Evaluative data collection includes two sections: the data acquired to evaluate patient outcomes and the time criteria for data collection.
Section...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same authorSame journal

US regulation of combination products.

Medical device technology·2010

Same author

Clinical studies in Italy.

Medical device technology·2010

Same author

Meeting US and European supplier control requirements.

Medical device technology·2009

Same author

Avoiding surprises when implementing a single quality system.

Medical device technology·2009

Same author

Addressing Eeuropean environmental legislation.

Medical device technology·2009

Same author

Addressing US and European device testing requirements.

Medical device technology·2008

Search research articles

Related Experiment Video

Updated: Jul 17, 2026

Reproducibility and Harmonization in Research Using Biological Standards: The Example of Platelet Agonist Collagen-Related Peptide

Reproducibility and Harmonization in Research Using Biological Standards: The Example of Platelet Agonist Collagen-Related Peptide

Published on: August 4, 2023

New efforts to harmonise clinical evaluation.

¹Donawa Consulting, Rome, Italy. medonawa@donawa.com

Medical Device Technology

|January 24, 2007

Summary

Global medical device manufacturers face diverse clinical data requirements. Harmonizing these regulations through proposed documents is crucial for market access and compliance.

Area of Science:

Medical Device Regulation
Clinical Data Analysis
Global Health Policy

Background:

Manufacturers seeking global market access encounter varied regulatory demands for clinical data.
Assessing and analyzing clinical data is essential for substantiating medical device safety and performance claims.
Disparate regulatory frameworks complicate international commercialization efforts for medical devices.

Purpose of the Study:

To highlight the challenges posed by varying international regulatory requirements for clinical data.
To discuss the necessity of harmonizing these regulatory demands.
To introduce and explain two proposed documents aimed at regulatory harmonization.

Main Methods:

Literature review of current global medical device regulations.

Related Experiment Videos

Last Updated: Jul 17, 2026

Reproducibility and Harmonization in Research Using Biological Standards: The Example of Platelet Agonist Collagen-Related Peptide

Reproducibility and Harmonization in Research Using Biological Standards: The Example of Platelet Agonist Collagen-Related Peptide

Published on: August 4, 2023

Analysis of existing frameworks for clinical data assessment.

Examination of proposed harmonization documents and their implications.

Main Results:

Significant variations exist in regulatory requirements for clinical data across different global markets.
Harmonization efforts are needed to streamline the process of medical device approval.
Two specific documents have been developed to facilitate regulatory convergence.

Conclusions:

Harmonizing regulatory requirements for clinical data is vital for global medical device manufacturers.
The proposed documents offer a pathway toward more consistent international standards.
Adoption of harmonized standards will improve efficiency and reduce barriers in the global medical device market.